Table 5.
OCV Coverage Survey: Characteristics of Participants and Coverage Estimate
| Characteristic | Households Surveyed (N = 277) | |
|---|---|---|
| ST (n = 112) | SW (n = 165) | |
| No. of household members, median (IQR) | 5.0 (4.0–6.0) | 6.0 (4.0–7.0) |
| Sex, no. (%)a | ||
| Female | 286 (52.96) | 477 (52.13) |
| Male | 254 (47.04) | 438 (47.87) |
| Totalb | 540 | 915 |
| Age group, no. (%)a | ||
| 1–4 y | 66 (12.20) | 147 (16.07) |
| 5–14 y | 162 (29.94) | 332 (36.28) |
| ≥15 y | 313 (57.86) | 436 (47.65) |
| All agesb | 541 | 915 |
| Estimated OCV coverage by age group, no. (% [95% CI])a,c | ||
| All agesc | ||
| 2 doses | 422 (78.00 [73.06–82.94]) | 760 (83.06 [79.62–86.50]) |
| 1 dose | 279 (51.57 [45.61–57.53]) | 803 (87.76 [84.76–90.76]) |
| 0 dosed | 91 (16.82 [12.36–21.28]) | 108 (11.80 [8.84–14.76]) |
| Age 1–4 y | ||
| 2 doses | 55 (83.33 [70.61–96.05]) | 115 (78.23 [68.80–87.66]) |
| 1 dose | 38 (57.58 [40.72–74.44]) | 117 (79.59 [70.38–88.80]) |
| 0 dosed | 10 (15.15 [2.92–27.38]) | 28 (19.05 [10.07–28.03]) |
| Age 5–14 y | ||
| 2 doses | 144 (88.89 [82.05–95.73]) | 302 (90.96 [86.60–95.32]) |
| 1 dose | 81 (50.00 [39.11–60.89]) | 308 (92.77 [88.83–96.71]) |
| 0 dosed | 11 (6.79 [1.31–12.27]) | 22 (5.05 [1.72–8.38]) |
| Age ≥15 y | ||
| 2 doses | 223 (71.25 [64.16–78.34]) | 343 (78.67 [73.23–84.11]) |
| 1 dose | 160 (51.12 [43.29–58.95]) | 378 (86.70 [82.19–91.21]) |
| 0 dosed | 70 (22.36 [15.83–28.89]) | 58 (13.30 [8.79–17.81]) |
Abbreviations: CI, confidence interval; IQR, interquartile range; OCV, oral cholera vaccine; ST, Shashemene Town; SW, Shashemene Woreda; y, years.
aAnalysis at individual level.
bAny discrepancies in total sums may be due to missing values in the data collected.
cBased on totals of 541 individuals for ST and 915 for SW.
dThe “0 dose” results represent household members who were not vaccinated (n = 199).